Trump Signs Order to Speed Psychedelic Drug Research, Expanding FDA Review of Ibogaine and Mental Health Treatments
U.S. President Donald Trump has signed a new executive order aimed at accelerating research and regulatory review of psychedelic-based medical treatments, marking a major federal shift in how certain previously…